Intrathecal administration of a new nitric oxide donor, NOC-18, produces acute thermal hyperalgesia in the rat

Journal of the Neurological Sciences

Volumn 153, Issue 1, 1997, Pages 1-7

  Inoue, Takaya ^a   Mashimo, Takashi ^a   Shibuta, Satoshi ^a   Yoshiya, Ikuto ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cyclic GMP; Hemoglobin; Hyperalgesia; Methylene blue; N Nitro L arginine methyl ester; Nitric oxide; NO releasing compounds; Nociception; Spinal cord

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; CYCLIC GMP; FREE RADICAL; HEMOGLOBIN; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HYPERALGESIA; INTRATHECAL DRUG ADMINISTRATION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; SYNAPTIC TRANSMISSION; TAIL FLICK TEST;

ANIMALS; ENZYME INHIBITORS; GUANYLATE CYCLASE; HEAT; HEMOGLOBINS; HYPERALGESIA; INJECTIONS, SPINAL; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROSO COMPOUNDS; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME;

EID: 0031460066     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00188-3     Document Type: Article

References (52)

1. Aanonsen L.M., Lei S., Wilcox G.L. Excitatory amino acid receptors and nociceptive neurotransmission in the rat spinal cord. Pain. 41:1990;309-321.
2. Babbedge R.C., Hart S.L., Moore P.K. Anti-nociceptive activity of nitric oxide synthase inhibitors in the mouse: dissociation between the effects of L-NAME and L-NMMA. J. Pharm. Pharmacol. 45:1993;77-79.
3. Bates J.N., Baker M.T., Guerra R.J., Harrison D.G. Nitric oxide generation from nitroprusside by vascular tissue. Biochem. Pharmacol. 42:1991;S157-S165.
4. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 368:1994;850-853.
5. Bredt D.S., Hwang P.M., Snyder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 347:1990;768-770.
6. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthetase, a calmoduline-requiring enzyme. Proc. Natl. Acad. Sci. USA. 87:1990;682-685.
7. Bredt D.S., Glatt C.E., Hwang P.M., Fotuhi M., Dawson T.M., Snyder S.H. Nitric oxide synthase protein and mRNA are discretely localized in neural populations of the mammalian CNS together with NADPH diaphorase. Neuron. 7:1991;615-624.
8. Bredt D.S., Snyder S.H. Nitric oxide, a novel neuroal messenger. Neuron. 8:1992;3-11.
9. Bruhwyler J., Chleide E., Liegeois J.F., Carreer F. Nitric oxide: A new messenger in the brain. Neurosci. Biobehav. Rev. 17:1993;373-384.
10. Bult H., Boeckxstaens G.E., Pelckmans P.A., Jordaens F.H., Van maercke Y.M., Herman A.G. Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature. 345:1990;346-347.
11. Cahusac P.M.B., Evans R.H., Hill R.G., Rodriguez R.E., Smith D.A.S. The behavioral effects of an N-methylaspartate receptor antagonist following application to the lumbar spinal cord of conscious rats. Neuropharmacology. 23:1984;719-724.
12. Coderre T.J., Yashpal K. Intracellular messengers contributing to persistent nociception and hyperalgesia induced by L-glutamate and substance P in the rat formalin pain model. Eur. J. Neurosci. 6:1994;1328-1334.
13. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74.
14. Feelisch M., Noack E.A. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur. J. Pharmacol. 139:1987;19-30.
15. Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J. Cardiovasc. Pharmacol. 17:1991;S25-S33.
16. Fesenko E.E., Kolesnikov S.S., Lyubarsky A.L. Induction by cyclic GMP of cationic conductance in plasma membrane of retinal rod outer segment. Nature. 313:1985;310-313.
17. Garthwaite J., Charles S.L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 336:1988;385-388.
18. Garthwaite J. Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci. 14:1991;60-67.
19. Gaston B., Drazen J.M., Jansen A., Sugarbaker D.A., Loscalzo J., Richards W., Stamler J.S. Relaxation of human bronchial smooth muscle by S-nitrosothiols in vivo. J. Pharmacol. Exp. Ther. 268:1994;978-984.
20. Gibson A., Mirzazadeh S., Hobbs A.J., Moore P.K. L-NG-Monomethyl arginine and L-NG-nitro arginine inhibit non-adrenergic non-cholinergic relaxation of the mouse anococcygeus. Br. J. Pharmacol. 99:1990;602-606.
21. Gillespie J.S., Liu X., Martin W. The effects of L-arginine and NG-monomethyl L-arginine on the response of the rat anococcygeus muscle to NANC nerve stimulation. Br. J. Pharmacol. 98:1989;1080-1082.
22. Hrabie J.A., Klose J.R., Wink D.A., Keefer L.K. New nitric oxide-releasing zwitterions derived from polyamines. J. Org. Chem. 58:1993;1472-1476.
23. Haefiger I.O., Zachauer A., Anderson D.A. Relaxation of retinal pericyte contractile tone through the nitric oxide-cyclic guanosine monophosphate pathway. Invest. Opthalmol. Vis. Sci. 35:1994;991-997.
24. Ignarro L.J. Nitric oxide: A novel signal transduction mechanism for transcellular communication. Hypertension. 16:1990;477-483.
25. Izumi Y., Benz A.M., Clifford D.B., Zorumski C.F. Neurotoxic effects of sodium nitroprusside in rat hippocampal slices. Exper. Neurol. 121:1993;14-23.
26. Katayama Y. NOC. Dojin News. 69:1994;21.
27. Kawabata A., Umeda N., Takagi H. L-Arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphine-Met-enkephalin pathway and NO-cyclic GMP pathway. Br. J. Pharmacol. 109:1993;73-79.
28. Kawabata A., Manabe S., Manabe Y., Takagi H. Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br. J. Pharmacol. 112:1994;547-550.
29. Kitto K.F., Haley J.E., Wilcox G.L. Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci. Lett. 148:1992;1-5.
30. Knowles R.G., Palacios M., Palmar R.M.J., Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. USA. 86:1989;5159-5162.
31. Leeuwenkamp O.R., van Bennekom W.P., van der Mark E.J., Bult A. Nitroprusside, antihypertensive drug and analytical reagent. Review of (photo)stability, pharmacology and analytical properties. Pharm. Weekbl. [Sci]. 6:1984;129-140.
32. Meller S.T., Dykstra C., Gebhart G.F. Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-D-aspartate-produced facilitation of the nociceptive tail-flick reflex. Eur. J. Pharmacol. 214:1992;93-96.
33. Meller S.T., Pechman P.S., Gebhart G.F., Maves T.J. Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience. 50:1992;7-10.
34. Meller S.T., Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain. 52:1993;127-136.
35. Moncada S., Palmar R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
36. Moore P.K., Oluyomi A.O., Babbedge R.C., Wallace P., Hart S.L. L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmacol. 102:1991;198-202.
37. 2+ current increase in snail neurons. Nature. 323:1986;812-814.
38. Raigorodsky G., Urca G. Intrathecal N-methyl-D-aspartate (NMDA) activates both nociceptive and antinociceptive systems. Brain Res. 422:1987;158-162.
39. Shibuki K., Okada D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature. 349:1991;326-328.
40. Shibuta S., Mashimo T., Ohara A., Zhang P., Yoshiya I. Intracerebroventricular administration of a nitric oxide-releasing compound, NOC-18, produces thermal hyperalgesia in rats. Neurosci. Lett. 187:1995;103-106.
41. Shibuta S., Mashimo T., Zhang P., Ohara A., Yoshiya I. A new nitric oxide donor, NOC-18, exhibits a nociceptive effect in the rat formalin model. J. Neurol. Sci. 141:1996;1-5.
42. Shimaoka M., Iida T., Ohara A., Taenaka N., Mashimo T., Honda T., Yoshiya I. NOC, a nitric-oxide-releasing compound, induces dose dependent apoptosis in macrophages. Biochem. Biophys. Res. Commun. 209:1995;519-526.
43. Shiga T., Hwang K.J., Tyuma I. Electron paramagnetic resonance studies of nitric oxide hemoglobin derivatives. I. Human hemoglobin subunits. Biochemistry. 8:1969;378-383.
44. Shuman E.M., Madison D.V. A requirement for the intercellular messenger nitric oxide in long-term potetiation. Science. 254:1991;1503-1506.
45. Snyder S.H., Bredt D.S. Nitric oxide as a neural messenger. Trends. Pharmacol. Sci. 12:1991;125-128.
46. Snyder S.H. Nitric oxide: first in a new class of neurotransmitters? Science. 257:1992;494-496.
47. Tseng L.F., Xu J.Y., Pieper G.M. Increasing of nitric oxide production by L-arginine potentiates i.c.v. administered β-endorphin-induced antinociception in the mouse. Eur. J. Pharmacol. 212:1992;301-303.
48. Tucker J.F., Brave S.R., Charalambous L., Hobbs A.J., Gibson A. L-NG-nitro arginine inhibits non-cholinergic relaxation of guinea pig trachia. Br. J. Pharmacol. 100:1990;663-664.
49. Vocci F.J., Petty S.K., Dewey W.L. Antinociceptive action of the butyryl derivatives of cyclic guanosine 3′5′-monophosphate. J. Pharmacol. Exp. Ther. 207:1978;892-898.
50. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17:1976;1031-1036.
51. Zhang P., Ohara A., Mashimo T., Sun J., Shibuta S., Takada K., Kosaka H., Terada M., yoshiya I. Cardiovascular effects of an ultra-short-acting nitric oxide-releasing compound, zwitterionic diamine/NO adduct, in dogs. Circulation. 94:1996;2235-2240.
52. Zhuo M., Meller S.T., Gebhart G.F. Endogenous nitric oxide is required for tonic cholinergic inhibition of spinal mechanical transmission. Pain. 54:1993;71-78.